Eric M. Dube

Insider Reports History

Location
San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric M. Dube:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 432,886 $14,155,372 $32.70 03 Feb 2026 Direct
Travere Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Employee stock option (right to buy) 303,600 31 Jan 2026 Direct
Travere Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Performance-based restricted stock units 18,924 02 May 2025 Direct
Reneo Pharmaceuticals, Inc. Director Stock Option (right to buy) 17,500 06 Jun 2023 Direct

Insider Reports Filed by Eric M. Dube

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TVTX Travere Therapeutics, Inc. 31 Jan 2026 4 -$3,230,316 4 CHIEF EXECUTIVE OFFICER, Director 03 Feb 2026, 21:30
TVTX Travere Therapeutics, Inc. 23 Jan 2026 6 -$877,534 4 CHIEF EXECUTIVE OFFICER, Director 27 Jan 2026, 20:25
TVTX Travere Therapeutics, Inc. 28 Oct 2025 6 -$1,783,232 4 CHIEF EXECUTIVE OFFICER, Director 30 Oct 2025, 16:45
TVTX Travere Therapeutics, Inc. 02 May 2025 3 -$398,350 4 CHIEF EXECUTIVE OFFICER, Director 05 May 2025, 21:53
TVTX Travere Therapeutics, Inc. 11 Feb 2025 1 -$273,455 4 CHIEF EXECUTIVE OFFICER, Director 12 Feb 2025, 21:23
TVTX Travere Therapeutics, Inc. 31 Jan 2025 3 -$1,024,343 4 CHIEF EXECUTIVE OFFICER, Director 04 Feb 2025, 20:30
TVTX Travere Therapeutics, Inc. 22 Jan 2025 1 -$208,923 4 CHIEF EXECUTIVE OFFICER, Director 23 Jan 2025, 20:39
TVTX Travere Therapeutics, Inc. 05 Sep 2024 2 -$243,360 4 CHIEF EXECUTIVE OFFICER, Director 09 Sep 2024, 21:20
TVTX Travere Therapeutics, Inc. 31 Jan 2024 4 -$166,435 4 CHIEF EXECUTIVE OFFICER, Director 02 Feb 2024, 16:06
TVTX Travere Therapeutics, Inc. 23 Jan 2024 1 -$70,542 4 CHIEF EXECUTIVE OFFICER, Director 25 Jan 2024, 16:10
TVTX Travere Therapeutics, Inc. 31 Aug 2023 2 -$65,533 4 Chief Executive Officer, Director 05 Sep 2023, 21:10
OKUR Reneo Pharmaceuticals, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 18:02
TVTX Travere Therapeutics, Inc. 31 Jan 2023 4 -$182,361 4 Chief Executive Officer, Director 02 Feb 2023, 17:58
TVTX Travere Therapeutics, Inc. 24 Jan 2023 1 -$138,503 4 Chief Executive Officer, Director 26 Jan 2023, 15:05
TVTX Travere Therapeutics, Inc. 05 Jan 2023 1 -$116,719 4 Chief Executive Officer, Director 06 Jan 2023, 15:05
OKUR Reneo Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 17:00
TVTX Travere Therapeutics, Inc. 10 Feb 2022 1 -$134,523 4 Chief Executive Officer, Director 11 Feb 2022, 15:05
TVTX Travere Therapeutics, Inc. 31 Jan 2022 4 -$131,876 4 Chief Executive Officer, Director 02 Feb 2022, 15:16
TVTX Travere Therapeutics, Inc. 24 Jan 2022 1 -$196,668 4 Chief Executive Officer, Director 26 Jan 2022, 15:33
TVTX Travere Therapeutics, Inc. 04 Jan 2022 3 -$521,407 4 Chief Executive Officer, Director 06 Jan 2022, 15:03
TVTX Travere Therapeutics, Inc. 13 Aug 2021 2 -$134,142 4 Chief Executive Officer, Director 17 Aug 2021, 19:40
TVTX Travere Therapeutics, Inc. 01 Jun 2021 2 -$139,797 4 Chief Executive Officer, Director 03 Jun 2021, 16:07